Kingsbury Capital Investment Advisors LLC

Position in ALZN — Alzamend Neuro, Inc.

CIK 1927315 Evanston, IL

Position in ALZN

as of Jun 30, 2026 · filed Aug 25, 2026 Compact

Position Value

$1,594,920

+$994,184 QoQ

Shares Held

1,329,100

+134.5% QoQ

Ownership

27.7%

of shares outstanding

% of Portfolio

1.79%

of 13F equity value

Holder Rank

of 12 holders

Holding Since

Mar 2022

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Kingsbury Capital Investment Advisors LLC holds $3,647,895 across 3 Biotechnology names. ALZN ranks #2 (43.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INTS	Intensity Therapeutics, Inc.	496,493	$2,035,621
2	ALZN	Alzamend Neuro, Inc. This page	1,329,100	$1,594,920
3	CHRS	Coherus Oncology, Inc.	12,396	$17,354

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,594,920	1,329,100	+134.5%	Shares	Sole	2026-08-25
2026-03-31	$600,736	566,733	+2161.6%	Shares	Sole	2026-08-25
2022-06-30	$21,650	25,059	+117.5%	Shares	Sole	2022-08-09
2022-03-31	$14,168	11,519	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.